GTN 2019

CBI’s longstanding Gross-to-Net Summit is built for biotech, pharma and generic drug companies of all sizes and stages. Whether your organization is pre-commercial revenue or is managing multiple products and large revenue streams, the GTN models and processes shared at the conference are paramount to success and compliance. Attendees walk away with best practices for a well-designed, multi-faceted approach to GTN management for enhanced visibility, profitability and control.

For more information, visit http://www.cbinet.com/conference/pc19269

Cumberland is a sponsor of the event.